Breast Cancer Trial, Recruiting NCT07416630 Sponsor: Institute of Oncology Ljubljana Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07416630
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are receiving radiation therapy for a gynaecological cancer, urological cancer, or breast cancer at the Institute of Oncology Ljubljana.
  • You are able to access and use a web-based app on a smartphone, computer, or tablet.
  • You are willing and able to sign a consent form agreeing to take part in the study.

Who may not be able to join:

  • You are unable to understand the questions in the questionnaire or provide meaningful answers to them.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +38615879273

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institute of Oncology Ljubljana
Registry
ClinicalTrials.gov
Start date
2 September 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇸🇮 Slovenia

Primary endpoints

Prediction of Radiotherapy-Related Adverse Effects Using Electronic Patient-Reported Outcome Measures (PROMs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov